USD 0.0
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2012 | 11.2 Million USD | 64.6% |
2011 | 6.8 Million USD | 100.01% |
2010 | 3.4 Million USD | -69.63% |
2009 | 11.2 Million USD | 560.85% |
2008 | 1.69 Million USD | 7.26% |
2007 | 1.58 Million USD | -73.08% |
2006 | 5.87 Million USD | 7.88% |
2005 | 5.44 Million USD | 1053.24% |
2004 | 472.25 Thousand USD | -75.56% |
2003 | 1.93 Million USD | -30.87% |
2002 | 2.79 Million USD | -40.98% |
2001 | 4.73 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2012 Q2 | 7.35 Million USD | -9.51% |
2012 FY | 11.2 Million USD | 64.6% |
2012 Q1 | 8.13 Million USD | 19.41% |
2012 Q3 | 9.89 Million USD | 34.55% |
2012 Q4 | 11.2 Million USD | 13.22% |
2011 Q1 | 3.36 Million USD | -1.14% |
2011 FY | 6.8 Million USD | 100.01% |
2011 Q4 | 6.8 Million USD | 28.15% |
2011 Q3 | 5.31 Million USD | 42.01% |
2011 Q2 | 3.74 Million USD | 11.17% |
2010 FY | 3.4 Million USD | -69.63% |
2010 Q2 | 3.73 Million USD | -67.8% |
2010 Q3 | 3.47 Million USD | -7.03% |
2010 Q4 | 3.4 Million USD | -1.97% |
2010 Q1 | 11.6 Million USD | 3.5% |
2009 Q1 | 1.76 Million USD | 4.06% |
2009 Q2 | 1.96 Million USD | 11.13% |
2009 Q3 | 2.12 Million USD | 8.14% |
2009 FY | 11.2 Million USD | 560.85% |
2009 Q4 | 11.2 Million USD | 428.45% |
2008 Q3 | 1.2 Million USD | 51.69% |
2008 FY | 1.69 Million USD | 7.26% |
2008 Q2 | 792.25 Thousand USD | -44.56% |
2008 Q1 | 1.42 Million USD | -9.64% |
2008 Q4 | 1.69 Million USD | 41.15% |
2007 Q3 | 2.8 Million USD | -41.6% |
2007 Q4 | 1.58 Million USD | -43.63% |
2007 FY | 1.58 Million USD | -73.08% |
2007 Q1 | 7.4 Million USD | 25.99% |
2007 Q2 | 4.8 Million USD | -35.11% |
2006 Q4 | 5.87 Million USD | -4.32% |
2006 Q2 | 6.63 Million USD | 0.68% |
2006 FY | 5.87 Million USD | 7.88% |
2006 Q1 | 6.58 Million USD | 20.95% |
2006 Q3 | 6.14 Million USD | -7.41% |
2005 Q3 | 4.84 Million USD | 11.29% |
2005 Q4 | 5.44 Million USD | 12.33% |
2005 Q2 | 4.35 Million USD | 445.82% |
2005 Q1 | 798.12 Thousand USD | 69.0% |
2005 FY | 5.44 Million USD | 1053.24% |
2004 Q3 | 274.01 Thousand USD | -28.0% |
2004 Q4 | 472.25 Thousand USD | 72.34% |
2004 FY | 472.25 Thousand USD | -75.56% |
2004 Q1 | 2.3 Million USD | 19.38% |
2004 Q2 | 380.58 Thousand USD | -83.5% |
2003 Q1 | 1.54 Million USD | -44.64% |
2003 Q2 | 2.55 Million USD | 64.91% |
2003 Q4 | 1.93 Million USD | -20.11% |
2003 FY | 1.93 Million USD | -30.87% |
2003 Q3 | 2.41 Million USD | -5.22% |
2002 Q4 | 2.79 Million USD | 17.73% |
2002 FY | 2.79 Million USD | -40.98% |
2002 Q2 | 3.28 Million USD | -2.72% |
2002 Q1 | 3.38 Million USD | 0.0% |
2002 Q3 | 2.37 Million USD | -27.8% |
2001 FY | 4.73 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Dong Fang Hui Le Inc. | 58.03 Thousand USD | -19210.977% |
NexgenRx Inc. | 16.96 Million USD | 33.927% |
Pacific Health Care Organization, Inc. | 1.02 Million USD | -998.504% |